RSS feed

Publications by Jean-Paul A. Bernard

15 publications found

Original articles

Smith RL, Molden E, Bernard JP (2023)
Effect of CYP2D6 and CYP2C19 genotypes on atomoxetine serum levels: A study based on therapeutic drug monitoring data
Br J Clin Pharmacol, 89 (7), 2246-2253
DOI 10.1111/bcp.15706, PubMed 36851891

Kringen MK, Chalabianloo F, Bernard JP, Bramness JG, Molden E, Høiseth G (2017)
Combined Effect of CYP2B6 Genotype and Other Candidate Genes on a Steady-State Serum Concentration of Methadone in Opioid Maintenance Treatment
Ther Drug Monit, 39 (5), 550-555
DOI 10.1097/FTD.0000000000000437, PubMed 28723731

Bernard JP, Khiabani HZ, Hilberg T, Karinen R, Slørdal L, Waal H, Mørland J (2015)
Characteristics of methadone-related fatalities in Norway
J Forensic Leg Med, 36, 114-20
DOI 10.1016/j.jflm.2015.09.011, PubMed 26439870

Hjelmeland K, Gustavsen I, Bernard JP, Mørland J (2015)
Can a simple clinical test detect impairment of zopiclone and alcohol? - A randomized controlled trial
Forensic Sci Int, 248, 129-33
DOI 10.1016/j.forsciint.2014.12.028, PubMed 25617762

Bernard JP, Havnes I, Slørdal L, Waal H, Mørland J, Khiabani HZ (2012)
Methadone-related deaths in Norway
Forensic Sci Int, 224 (1-3), 111-6
DOI 10.1016/j.forsciint.2012.11.010, PubMed 23246070

Gustavsen I, Hjelmeland K, Bernard JP, Mørland J (2012)
Individual psychomotor impairment in relation to zopiclone and ethanol concentrations in blood--a randomized controlled double-blinded trial
Addiction, 107 (5), 925-32
DOI 10.1111/j.1360-0443.2011.03693.x, PubMed 22008377

Gustavsen I, Hjelmeland K, Bernard JP, Mørland J (2011)
Psychomotor performance after intake of zopiclone compared with intake of ethanol: a randomized, controlled, double-blinded trial
J Clin Psychopharmacol, 31 (4), 481-8
DOI 10.1097/JCP.0b013e3182214be6, PubMed 21694628

Vindenes V, Yttredal B, Oiestad EL, Waal H, Bernard JP, Mørland JG, Christophersen AS (2011)
Oral fluid is a viable alternative for monitoring drug abuse: detection of drugs in oral fluid by liquid chromatography-tandem mass spectrometry and comparison to the results from urine samples from patients treated with Methadone or Buprenorphine
J Anal Toxicol, 35 (1), 32-9
DOI 10.1093/anatox/35.1.32, PubMed 21219701

Gjerde H, Øiestad EL, Øiestad ÅM, Langødegård M, Gustavsen I, Hjelmeland K, Bernard JP, Christophersen AS (2010)
Comparison of zopiclone concentrations in oral fluid sampled with Intercept(®) oral specimen collection device and Statsure Saliva Sampler™ and concentrations in blood
J Anal Toxicol, 34 (9), 590-3
DOI 10.1093/jat/34.9.590, PubMed 21073813

Bernard JP, Mørland J, Krogh M, Khiabani HZ (2009)
Methadone and impairment in apprehended drivers
Addiction, 104 (3), 457-64
DOI 10.1111/j.1360-0443.2008.02470.x, PubMed 19207356

Vindenes V, Karinen R, Hasvold I, Bernard JP, Mørland JG, Christophersen AS (2008)
Bromadiolone poisoning: LC-MS method and pharmacokinetic data
J Forensic Sci, 53 (4), 993-6
DOI 10.1111/j.1556-4029.2008.00737.x, PubMed 18482378

Høiseth G, Bernard JP, Stephanson N, Normann PT, Christophersen AS, Mørland J, Helander A (2008)
Comparison between the urinary alcohol markers EtG, EtS, and GTOL/5-HIAA in a controlled drinking experiment
Alcohol Alcohol, 43 (2), 187-91
DOI 10.1093/alcalc/agm175, PubMed 18230699

Bernard JP, Opdal MS, Karinen R, Mørland J, Khiabani HZ (2007)
Relationship between methadone and EDDP (2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine) in urine samples from Norwegian prisons
Eur J Clin Pharmacol, 63 (8), 777-82
DOI 10.1007/s00228-007-0314-4, PubMed 17576548

Other articles

Frost J, Bernard JP, Dietrichs ES, Kjeldstadli K, Riedel B, Skrastad RB, Vevelstad M, Helland A (2019)
New recommendations for serum concentration measurements of central stimulant drugs
Tidsskr. Nor. Laegeforen., 139 (13), 1230-1231

Karlsen Bjånes T, Mjåset Hjertø E, Lønne L, Aronsen L, Andsnes Berg J, Bergan S, Otto Berg-Hansen G, Bernard JP, Larsen Burns M, Toralf Fosen J, Frost J, Hilberg T, Krabseth HM, Kvan E, Narum S, Austgulen Westin A (2015)
Pharmacology Portal: An Open Database for Clinical Pharmacologic Laboratory Services
Clin Ther, 38 (1), 222-6
DOI 10.1016/j.clinthera.2015.10.015, PubMed 26546404